A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...
Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics, today announced the appointment of Professor Dr. Carl Wittwer (picture), a global authority in PCR ...
Local Profile on MSN
Making Healthcare More Accessible: How McKinney’s OSPRI Is Changing Disease Testing
McKinney is now home to one of the world’s first fully vertically integrated molecular testing platforms. Community Direct DX, Scienetix and the R&D division of Advanta Genetics have merged to form ...
When COVID first hit, waiting days for laboratory results from an ultrasensitive polymerase chain reaction (PCR) test was commonplace. Faster tests usable by anyone, anywhere, later became widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback